stockrowBausch + Lomb Corporation (BLCO) vs Repligen Corporation (RGEN)
- Bausch + Lomb Corporation BLCO 19.94 −3.20%
- Repligen Corporation RGEN 169.01 −5.16%
Bausch + Lomb Corporation and Repligen Corporation are both Medical Instruments & Supplies companies. Repligen Corporation is the larger, with a market value of $10.8B against $7.1B — 1.5× the size. Repligen Corporation grew revenue faster over the last twelve months: 13.8% against 8.88%. Repligen Corporation has the higher net margin (−1.47% vs −2.05%) and the lower return on invested capital (0.64% vs 2.16%). Across the 21 metrics below, Repligen Corporation leads on 11 and Bausch + Lomb Corporation on 10.
Valuation
Profitability
| Metric | BLCO | RGEN | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 62.55% | 53.46% | 53.60% |
| Operating margin | 7.07% | 2.26% | 1.97% |
| Net margin | (2.05%) | (1.47%) | 0.00% |
| Free cash flow margin | 4.65% | 13.09% | 2.36% |
| Return on equity | (1.71%) | (0.57%) | 0.00% |
| Return on assets | (0.80%) | (0.40%) | 0.00% |
| Return on invested capital | 2.16% | 0.64% | 0.13% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack